Cryoballoon ablation as salvage therapy after nonradical resection of a high-risk T1b esophageal adenocarcinoma

Standard

Cryoballoon ablation as salvage therapy after nonradical resection of a high-risk T1b esophageal adenocarcinoma : a case report. / Frederiks, Charlotte N.; van de Water, Jolanda M. W.; Ebrahimi, Gati et al.

In: European journal of gastroenterology & hepatology, Vol. 34, No. 3, 01.03.2022, p. 354-357.

Research output: Contribution to journal › Article › Academic › peer-review

Author

Frederiks, Charlotte N. ; van de Water, Jolanda M. W. ; Ebrahimi, Gati et al. / Cryoballoon ablation as salvage therapy after nonradical resection of a high-risk T1b esophageal adenocarcinoma : a case report. In: European journal of gastroenterology & hepatology. 2022 ; Vol. 34, No. 3. pp. 354-357.

BibTeX

@article{812c9411dc444b489eca6172a0abe2b0,

title = "Cryoballoon ablation as salvage therapy after nonradical resection of a high-risk T1b esophageal adenocarcinoma: a case report",

abstract = "Although esophagectomy with or without (neo)adjuvant chemoradiation therapy is the current standard of care for patients with early esophageal adenocarcinoma with high-risk features or after nonradical endoscopic resection of an early esophageal adenocarcinoma, not all patients are eligible for surgery due to varying reasons. In these patients, cryoballoon ablation may serve as an alternative treatment option considering the potential of deeper tissue ablation as compared to heat-based ablation techniques. We report the first case in which cryoballoon ablation was successfully performed as salvage therapy with a curative intent for positive deep resection margins after an incomplete endoscopic resection of a recurrent early esophageal adenocarcinoma.",

keywords = "case report, cryoballoon ablation, cryotherapy, esophageal adenocarcinoma, esophageal cancer",

author = "Frederiks, {Charlotte N.} and {van de Water}, {Jolanda M. W.} and Gati Ebrahimi and Weusten, {Bas L. A. M.}",

note = "Funding Information: C.N.F. receives reimbursement of study-related travel costs from PENTAX Medical for an IRB-approved European, multicenter prospective study. B.L.A.M.W. receives research funding from PENTAX Medical, C2 Therapeutics and Aqua Medical. For the remaining authors there are no conflicts of interest. Publisher Copyright: {\textcopyright} 2022 Lippincott Williams and Wilkins. All rights reserved.",

year = "2022",

month = mar,

day = "1",

doi = "10.1097/MEG.0000000000002242",

language = "English",

volume = "34",

pages = "354--357",

journal = "European journal of gastroenterology & hepatology",

issn = "0954-691X",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

RIS

TY - JOUR

T1 - Cryoballoon ablation as salvage therapy after nonradical resection of a high-risk T1b esophageal adenocarcinoma

T2 - a case report

AU - Frederiks, Charlotte N.

AU - van de Water, Jolanda M. W.

AU - Ebrahimi, Gati

AU - Weusten, Bas L. A. M.

N1 - Funding Information: C.N.F. receives reimbursement of study-related travel costs from PENTAX Medical for an IRB-approved European, multicenter prospective study. B.L.A.M.W. receives research funding from PENTAX Medical, C2 Therapeutics and Aqua Medical. For the remaining authors there are no conflicts of interest. Publisher Copyright: © 2022 Lippincott Williams and Wilkins. All rights reserved.

PY - 2022/3/1

Y1 - 2022/3/1

N2 - Although esophagectomy with or without (neo)adjuvant chemoradiation therapy is the current standard of care for patients with early esophageal adenocarcinoma with high-risk features or after nonradical endoscopic resection of an early esophageal adenocarcinoma, not all patients are eligible for surgery due to varying reasons. In these patients, cryoballoon ablation may serve as an alternative treatment option considering the potential of deeper tissue ablation as compared to heat-based ablation techniques. We report the first case in which cryoballoon ablation was successfully performed as salvage therapy with a curative intent for positive deep resection margins after an incomplete endoscopic resection of a recurrent early esophageal adenocarcinoma.

AB - Although esophagectomy with or without (neo)adjuvant chemoradiation therapy is the current standard of care for patients with early esophageal adenocarcinoma with high-risk features or after nonradical endoscopic resection of an early esophageal adenocarcinoma, not all patients are eligible for surgery due to varying reasons. In these patients, cryoballoon ablation may serve as an alternative treatment option considering the potential of deeper tissue ablation as compared to heat-based ablation techniques. We report the first case in which cryoballoon ablation was successfully performed as salvage therapy with a curative intent for positive deep resection margins after an incomplete endoscopic resection of a recurrent early esophageal adenocarcinoma.

KW - case report

KW - cryoballoon ablation

KW - cryotherapy

KW - esophageal adenocarcinoma

KW - esophageal cancer

UR - http://www.scopus.com/inward/record.url?scp=85123968801&partnerID=8YFLogxK

U2 - 10.1097/MEG.0000000000002242

DO - 10.1097/MEG.0000000000002242

M3 - Article

C2 - 34231521

VL - 34

SP - 354

EP - 357

JO - European journal of gastroenterology & hepatology

JF - European journal of gastroenterology & hepatology

SN - 0954-691X

IS - 3

ER -

ID: 24162074

Generic Portal